These findings reinforce the critical complicity of an associated prolipogenic scenario induced by either an inherently upregulated hepatic lipogenesis or a high fat/high carbohydrate diet in CYP2E1-mediated NAFLD/NASH. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.